These newer therapies, including copyright , belong to a group of drugs called GLP-1 receptor agonists . Initially developed for treating type 2 diabetes , they operate by assisting the pancreas to release adequate insulin and reducing high sugar levels. Beyond diabetes, their capacity to promote weight management has contributed to significant … Read More